SCIENTIFIC RESEARCH: AUXOLOGICO’S RESULTS IN 2024

With the beginning of the new year, Auxologico reflects on the progress made in scientific research throughout 2024 and its highlights. Professor Gianfranco Parati, Scientific Director of Auxologico IRCCS, provides an overview of the year’s accomplishments.

Recognition and Appreciation for Researchers
The start of the new year serves as a moment to evaluate the advancements achieved at Auxologico, particularly during a challenging period. The Management and Scientific Secretariat of Auxologico IRCCS recognize the efforts of all researchers throughout the year, which have resulted in a significant increase in scientific output in indexed journals.

Results Achieved
As of December 6, the raw impact factor for 2023 stood at 3,102, whereas in 2024, it reached 4,438, reflecting a 43% increase, with a total of 482 publications in indexed journals.

The research activities carried out at Auxologico have garnered numerous national and international recognitions in 2024, evidenced by the high quality of published studies and the prestigious awards received by several researchers.

During the Auxologico Research Day, several young researchers were acknowledged for their significant contributions, which included securing funding through competitive grants and publishing findings in high-impact journals.

Awarded Research Studies
The awarded studies addressed key medical advancements, including:

  • New diagnostic procedures for heart failure with preserved systolic function;
  • Innovative therapeutic strategies to reduce the risk of sudden death in long QT syndrome;
  • The relationship between thyroid cancer treatment outcomes and the presence of autoimmune thyroiditis;
  • Identification of clinical characteristics relevant to the diagnosis of amyotrophic lateral sclerosis (ALS).

In addition, a multicenter study was recognized for investigating the prevalence of autoantibodies against neuronal surface antigens in cases of cognitive decline not seemingly linked to autoimmune encephalitis, aiming to assess their influence on disease progression.

Goals for 2025
The coming year presents new challenges aimed at sustaining and enhancing both the volume and quality of scientific research. Continuous efforts will be directed towards ensuring that research outcomes contribute to improving the effectiveness of medical treatments and patient care.

References: Auxologico News

LEARN MORE

All procedures are performed laparoscopically and involve the reduction of stomach size. Consistent citation and clear formatting will be maintained throughout the document. This can be achieved through the partial removal of the stomach or by preventing food from passing through it. These methods reduce feelings of hunger and early satiety, resulting in weight loss and improvement or resolution of associated conditions. Abbreviations such as “BMI” and “BPD-DS” will be explained upon first use. Sentences will follow common structures, avoid jargon, and offer precise definitions where appropriate.

Thanks to the use of the latest and safest technology in our operating theatre, including 4K and 3D laparoscopic imaging systems, automatic mechanical suturing and ultrasonic dissection and coagulation devices, patients at Auxologico are able to recover faster and enjoy shorter hospital stays.

Please find below a list of the procedures available at Auxologico.

SURGICAL PROCEDURES UNDER GENERAL ANAESTHESIA

  • Sleeve gastrectomy;
  • Roux-en-Y Gastric bypass and modified Roux-en-Y gastric bypass surgery; 
  • Single anastomosis gastric bypass or mini gastric bypass;
  • Adjustable gastric banding;
  • BariClip or B-clamp gastroplasty.

ENDOSCOPIC, NON-SURGICAL PROCEDURES

  • Intragastric balloon placement;
  • Gastric plication with Overstitch technique as a primary procedure, or after weight gain following sleeve gastrectomy or gastric by-pass.